OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

AstraZeneca selects OHSU Knight Cancer Institute as global ‘partner of choice’

AstraZeneca selects OHSU Knight Cancer Institute as global ‘partner of choice’

OHSU will join the company’s global precision oncology network, enhance real-time information, knowledge sharing to benefit patients.